GeneBiology, Inc.
↗Research Triangle Park, North Carolina, USA
GeneBiology, Inc. is a specialty pharmaceutical company based in Research Triangle Park, North Carolina, focused on the development of improved drug formulations using the FDA's 505(b)(2) regulatory pathway. The company leverages its expertise in medicine, drug development, and formulation chemistry to identify and market patented new formulations, routes of administration, and indications for previously approved medicines.
By utilizing the 505(b)(2) pathway, GeneBiology aims to reduce the time, cost, and risk associated with drug development by referencing existing safety and efficacy data. The company's primary focus areas include CNS-related conditions such as vertigo and motion sickness, as well as oncology, specifically targeting breast cancer patients who have failed standard hormonal therapies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Drug Reformulation (505(b)(2))
SIZE & FINANCIALS
Employees:1-50
Revenue:Pre-revenue
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Private
Investors:Piedmont Capital Investments
PIPELINE
Stage:Clinical
Lead Drug Stage:Phase 1/2
Modalities:Small molecule
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University of North Carolina at Chapel Hill (Philanthropic/Academic connection)
COMPETITION
Position:Niche Player
Competitors:Eagle Pharmaceuticals, Camurus, Evoke Pharma, Otonomy, Inc.
LEADERSHIP
Key Executives:
Walker A. Long, MD - President & CEO
Scientific Founders:Walker A. Long, MD, Edwin Curran Murphy, III
Board Members:Walker A. Long, MD, David Mottola, PhD (Former)
LINKS
Website:genebiology.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GeneBiology, Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.